Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability

Yahoo FinanceDec 20 18:39

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Ultragenyx Pharmaceutical (RARE) and Henry Schein (HSIC)

TipRanksDec 16 14:40 · Ratings

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireDec 14 05:05

Express News | Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 14 05:05

Evolus (NASDAQ:EOLS) Is Carrying A Fair Bit Of Debt

Simply Wall StDec 3 22:44

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 15:13